Clinical Trials Browser

Phase 2 × Uveal Melanoma × pasireotide × Clear all

NCT01252251 2017-08-01

RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma

Phase 2 Completed

14 enrolled 12 charts

Uveal Melanoma